{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23720270",
  "DateCompleted": {
    "Year": "2013",
    "Month": "11",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/cphy.c110065"
    ],
    "Journal": {
      "ISSN": "2040-4603",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "4",
        "PubDate": {
          "Year": "2012",
          "Month": "Oct"
        }
      },
      "Title": "Comprehensive Physiology",
      "ISOAbbreviation": "Compr Physiol"
    },
    "ArticleTitle": "Exercise training and peripheral arterial disease.",
    "Pagination": {
      "StartPage": "2933",
      "EndPage": "3017",
      "MedlinePgn": "2933-3017"
    },
    "Abstract": {
      "AbstractText": [
        "Peripheral arterial disease (PAD) is a common vascular disease that reduces blood flow capacity to the legs of patients. PAD leads to exercise intolerance that can progress in severity to greatly limit mobility, and in advanced cases leads to frank ischemia with pain at rest. It is estimated that 12 to 15 million people in the United States are diagnosed with PAD, with a much larger population that is undiagnosed. The presence of PAD predicts a 50% to 1500% increase in morbidity and mortality, depending on severity. Treatment of patients with PAD is limited to modification of cardiovascular disease risk factors, pharmacological intervention, surgery, and exercise therapy. Extended exercise programs that involve walking approximately five times per week, at a significant intensity that requires frequent rest periods, are most significant. Preclinical studies and virtually all clinical trials demonstrate the benefits of exercise therapy, including improved walking tolerance, modified inflammatory/hemostatic markers, enhanced vasoresponsiveness, adaptations within the limb (angiogenesis, arteriogenesis, and mitochondrial synthesis) that enhance oxygen delivery and metabolic responses, potentially delayed progression of the disease, enhanced quality of life indices, and extended longevity. A synthesis is provided as to how these adaptations can develop in the context of our current state of knowledge and events known to be orchestrated by exercise. The benefits are so compelling that exercise prescription should be an essential option presented to patients with PAD in the absence of contraindications. Obviously, selecting for a lifestyle pattern that includes enhanced physical activity prior to the advance of PAD limitations is the most desirable and beneficial."
      ],
      "CopyrightInformation": "\u00a9 2012 American Physiological Society"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Angiogenesis Research Group, Muscle Health Research Centre, Faculty of Health, York University, Toronto, Ontario, Canada."
          }
        ],
        "LastName": "Haas",
        "ForeName": "Tara L",
        "Initials": "TL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lloyd",
        "ForeName": "Pamela G",
        "Initials": "PG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yang",
        "ForeName": "Hsiao-Tung",
        "Initials": "HT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Terjung",
        "ForeName": "Ronald L",
        "Initials": "RL"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 HL084494",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R37 AR021617",
        "Acronym": "AR",
        "Agency": "NIAMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "T32 AR048523",
        "Acronym": "AR",
        "Agency": "NIAMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R37-AR21617",
        "Acronym": "AR",
        "Agency": "NIAMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "F32-HL10406",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "F32 HL010406",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 HL037387",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "F32-HL10485",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01-HL084494",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01-HL37387",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P01-HL52490",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "T32-AR048523",
        "Acronym": "AR",
        "Agency": "NIAMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "F32 HL010485",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P01 HL052490",
        "Acronym": "HL",
        "Agency": "NHLBI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Compr Physiol",
    "NlmUniqueID": "101574442",
    "ISSNLinking": "2040-4603"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Adaptation, Physiological"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Capillaries"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Collateral Circulation"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Mitochondria, Muscle"
    },
    {
      "QualifierName": [
        "blood supply",
        "physiopathology"
      ],
      "DescriptorName": "Muscle, Skeletal"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Neovascularization, Pathologic"
    },
    {
      "QualifierName": [
        "epidemiology",
        "physiopathology",
        "rehabilitation"
      ],
      "DescriptorName": "Peripheral Vascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quality of Life"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Regional Blood Flow"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Vasodilation"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Walking"
    }
  ]
}